SCYNEXIS INC - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by SCYNEXIS, Inc. on March 8, 2019, reporting events that occurred on March 7, 2019. The filing details the entry into a material definitive agreement involving the issuance of debt securities.
Key Financial Metrics and Transaction Details
The company issued and sold $16 million aggregate principal amount of 6.0% Convertible Senior Notes due 2025 to Puissance Life Science Opportunities Fund VI. The notes were sold at 100% of their principal amount for cash.
- Principal Amount: $16 million
- Interest Rate: 6.0% per annum, payable semiannually
- Maturity Date: March 15, 2025
- Initial Conversion Price: Approximately $1.35 per share (739.0983 shares per $1,000 principal)
- Conversion Cap: 813 shares per $1,000 principal amount
- Redemption Rights: Company may redeem on or after March 15, 2022, if stock price exceeds 130% of conversion price for 20 of 30 trading days.
The filing text does not provide specific values for revenue, profit, cash flow, margins, or existing debt levels outside of this new transaction.
Material Changes
The primary material change is the creation of a new direct financial obligation of $16 million. This transaction increases the company's debt load and introduces potential future equity dilution upon conversion of the notes.
Outlook, Risks, and Contingencies
The notes are general, senior unsecured obligations. Key contingencies and risks include:
- Conversion Risk: Holders may convert notes into common stock, subject to a share cap, potentially diluting existing shareholders.
- Repurchase Obligation: In the event of a "fundamental change," the company must offer to repurchase the notes at 100% of principal plus accrued interest.
- Default Provisions: Bankruptcy or insolvency events trigger automatic acceleration of principal and interest. Other defaults allow holders of 25% of notes to accelerate payment, though reporting covenant failures initially result only in additional interest for 180 days.
- Registration Rights: The company granted registration rights for the resale of shares issuable upon conversion.
Investor Verification Checklist
- Verify the company's current cash position to assess ability to service the new $16 million debt and pay semiannual interest.
- Review the full Note Purchase Agreement (Exhibit 10.1) for specific definitions of "fundamental change" and adjustment mechanisms.
- Assess the potential dilution impact based on the conversion cap of 813 shares per $1,000 principal.
- Confirm the company's compliance with reporting covenants to avoid default triggers.